Safety fears as scientists make first viruses designed by AI

AI-designed biological agents have moved from protein prediction into functioning viruses. Researchers created bacteriophages, viruses that infect bacteria rather than humans, and found that a cocktail of the generated phages killed E. coli strains that resisted naturally occurring phages. The result points to a potential new route for treating persistent, drug-resistant infections, especially when existing phage libraries fail. For AI practitioners, the work is also a concrete biosecurity warning: generative systems can now help produce viable organisms, not just suggest molecular structures. Bacteriophages are already used clinically in some settings, but the same design capabilities will require tighter controls around model access, sequence screening, laboratory validation, and disclosure. The report does not specify the AI models, success rates, or clinical availability, so this remains an early laboratory result rather than a deployable therapy.